NCT04241367View on ClinicalTrials.gov

Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

Active, not recruitingOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

June 3, 2021

Study Completion Date

December 31, 2025

Conditions
Pancreas Adenocarcinoma
Trial Locations (1)

410-769

NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT04241367 - Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy | Biotech Hunter | Biotech Hunter